Ownership

Chris Freeman - Chief Commercial Officer at Guardant Health, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Commercial Officer
Stock Symbol: GH on Nasdaq
Industry: Services-Medical Laboratories
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Chris Freeman since 3/5/2024

Holdings reported by Chris Freeman for Guardant Health, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	38.8K	$1.65M	$42.55	Mar 1, 2025	Direct
Performance-Based Restricted Stock Units	11.4K	$534K	$46.98	Mar 1, 2025	Direct	Common Stock
Restricted Stock Units	11.7K	$357K	$30.55	Jan 1, 2025	Direct	Common Stock
Stock Option (Right to Buy)	45.2K			Nov 8, 2024	Direct	Common Stock

Showing 1 to 4 of 4 entries

Transactions reported by Chris Freeman for Guardant Health, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.